Adage Capital Partners’s EPIRUS BIOPHARMACEUTICALS INC COM EPRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-772,007
Closed -$349K 768
2016
Q2
$349K Hold
772,007
﹤0.01% 674
2016
Q1
$2.08M Hold
772,007
0.01% 644
2015
Q4
$2.39M Buy
772,007
+250,000
+48% +$1.13M 0.01% 645
2015
Q3
$2.31M Hold
522,007
0.01% 671
2015
Q2
$2.98M Hold
522,007
0.01% 666
2015
Q1
$4.67M Hold
522,007
0.01% 636
2014
Q4
$2.96M Hold
522,007
0.01% 654
2014
Q3
$3.75M Buy
+522,007
New +$4.51M 0.01% 638

Other funds holding EPRS

Adage Capital Partners's EPRS Position: Q3 2016 in Review

Adage Capital Partners sold out of EPIRUS BIOPHARMACEUTICALS INC COM (EPRS) in Q3 2016, closing a stake of 772,007 shares — an estimated $349K sold.

Adage Capital Partners first reported a position in EPRS in Q3 2014 and held it in 8 quarters. The position peaked at $4.67M in Q1 2015. 3 funds tracked by Wall St. Rank hold EPRS as of Q3 2016.

  • Adage Capital Partners reported no remaining EPIRUS BIOPHARMACEUTICALS INC COM position as of Q3 2016 after selling out during the quarter.
  • Adage Capital Partners sold 772,007 EPIRUS BIOPHARMACEUTICALS INC COM shares in Q3 2016, an estimated $349K.
  • Adage Capital Partners first reported a position in EPIRUS BIOPHARMACEUTICALS INC COM in Q3 2014 and held it in 8 quarters.
  • Adage Capital Partners's EPIRUS BIOPHARMACEUTICALS INC COM position peaked at $4.67M in Q1 2015.
  • 3 funds tracked by Wall St. Rank held EPIRUS BIOPHARMACEUTICALS INC COM as of Q3 2016.

Based on Adage Capital Partners's 13F filing for Q3 2016, filed 14 Nov 2016.